Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Moodys
Boehringer Ingelheim
Mallinckrodt
AstraZeneca

Last Updated: June 29, 2022

CLOBEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Clobex, and what generic alternatives are available?

Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. There is one patent protecting this drug and three Paragraph IV challenges.

This drug has thirty-two patent family members in twenty-one countries.

The generic ingredient in CLOBEX is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clobex

A generic version of CLOBEX was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Try it Free

Drug patent expirations by year for CLOBEX
Drug Prices for CLOBEX

See drug prices for CLOBEX

Drug Sales Revenue Trends for CLOBEX

See drug sales revenues for CLOBEX

Recent Clinical Trials for CLOBEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
MC2 TherapeuticsPhase 1
Drug Delivery Solutions Ltd. (part of MC2 Therapeutics)Phase 1
University of California, San FranciscoPhase 4

See all CLOBEX clinical trials

Pharmacology for CLOBEX
Paragraph IV (Patent) Challenges for CLOBEX
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CLOBEX Spray clobetasol propionate 0.05% 021835 1 2008-09-29
CLOBEX Topical Shampoo clobetasol propionate 0.05% 021644 1 2008-01-09
CLOBEX Lotion clobetasol propionate 0.05% 021535 1 2006-03-27

US Patents and Regulatory Information for CLOBEX

CLOBEX is protected by one US patents.

Patents protecting CLOBEX

Foaming compositions for hair care
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TOPICAL TREATMENT OF SCALP PSORIASIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp CLOBEX clobetasol propionate LOTION;TOPICAL 021535-001 Jul 24, 2003 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Galderma Labs CLOBEX clobetasol propionate SHAMPOO;TOPICAL 021644-001 Feb 5, 2004 AB RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Galderma Labs Lp CLOBEX clobetasol propionate SPRAY;TOPICAL 021835-001 Oct 27, 2005 AT RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CLOBEX

International Patents for CLOBEX

See the table below for patents covering CLOBEX around the world.

Country Patent Number Title Estimated Expiration
World Intellectual Property Organization (WIPO) 9965456 See Plans and Pricing
Israel 121769 TOPICAL COMPOSITIONS IN THE FORM OF OIL-IN-WATER FLUID EMULSION WITH A HIGH CONTENT OF PRO-PENETRATING GYLCOL See Plans and Pricing
South Africa 9708353 See Plans and Pricing
Poland 187891 See Plans and Pricing
Hungary 0102190 See Plans and Pricing
European Patent Office 1695691 Composition moussante pour le lavage et le traitement des cheveux (Foaming composition for hair cleaning and hair treatment) See Plans and Pricing
Hungary 228518 FOAMING COMPOSITION FOR HAIR CARE See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Medtronic
Merck
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.